Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

被引:0
|
作者
David R. Coghill
Tobias Banaschewski
Peter Nagy
Isabel Hernández Otero
César Soutullo
Brian Yan
Beatriz Caballero
Alessandro Zuddas
机构
[1] University of Melbourne,Departments of Paediatrics and Psychiatry, Faculty of Medicine, Dentistry and Health Sciences
[2] University of Dundee,Central Institute of Mental Health
[3] Medical Faculty Mannheim,Child and Adolescent Neuropsychiatry Unit, Department of Biomedical Sciences
[4] University of Heidelberg,undefined
[5] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,undefined
[6] University Hospital Virgen de la Victoria,undefined
[7] University of Navarra Clinic,undefined
[8] Shire,undefined
[9] Shire,undefined
[10] University of Cagliari,undefined
来源
CNS Drugs | 2017年 / 31卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:625 / 638
页数:13
相关论文
共 50 条
  • [41] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    EPILEPSIA, 2005, 46 : 118 - 118
  • [42] Long-term efficacy of risperidone and haloperidol in children and adolescents with autistic disorder: An open-label maintenance study
    Gencer, OB
    Emiroglu, N
    Miral, S
    Baykara, BH
    Baykara, A
    Dirik, E
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 89S - 89S
  • [43] Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study
    Jankovic, Joseph
    Coffey, Barbara
    Claassen, Daniel O.
    Jimenez-Shahed, Joohi
    Gertz, Barry J.
    Garofalo, Elizabeth A.
    Stamler, David A.
    Wieman, Maria
    Savola, Juha-Matti
    Harary, Eran
    Alexander, Jessica
    Barkay, Hadas
    Gordon, Mark Forrest
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (09): : 1388 - 1398
  • [44] EFFICACY OF LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
    Delbello, Melissa P.
    Goldman, Robert S.
    Tocco, Michael
    Pikalov, Andrei A.
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S231 - S231
  • [45] Efficacy and tolerability of long-term, open-label, mixed amphetamine salts extended realease in adolescents with ADHD
    Spencer, TJ
    Biederman, J
    Wilens, TE
    CNS SPECTRUMS, 2005, 10 (10) : 14 - 21
  • [46] Long-term safety of ketoconazole foam 2% in the treatment of seborrheic dermatitis: Results of a phase IV, open-label study
    Draelos, Zoe
    Saenz, Alessandra Alio
    Feldman, Steven R.
    Butners, Victoria
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB56 - AB56
  • [47] Long-Term Efficacy and Safety of Inotersen for Hereditary Transthyretin Amyloidosis: NEURO-TTR Open-Label Extension 2-Year Update
    Brannagan, Thomas
    Cruz, Marcia Waddington
    Wang, Annabel K.
    Polydefkis, Michael J.
    Dyck, Peter J.
    Khella, Sami
    Plante-Bordeneuve, Violaine
    Berk, John L.
    Barroso, Fabio
    Merlini, Giampaolo
    Conceicao, Isabel
    Hughes, Steven G.
    Kwoh, Jesse
    Jung, Shiangtung W.
    Guthrie, Spencer
    Pollock, Michael
    Benson, Merrill D.
    Gertz, Morie
    Coelho, Teresa
    NEUROLOGY, 2019, 92 (15)
  • [48] Open-label, long-term safety study of zonisamide administered to children with epilepsy
    Shinnar, S
    Pellock, JM
    Conry, JA
    NEUROLOGY, 2006, 66 (05) : A37 - A37
  • [49] Long-Term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: 2-year results from the NEURO-TTR open-label extension study
    Brannagan, T.
    Waddington Cruz, M.
    Wang, A. K.
    Polydefkis, M. J.
    Dyck, P. J.
    Khella, S.
    Plante-Bordeneuve, V.
    Berk, J. L.
    Barroso, F.
    Merlini, G.
    Conceicao, I.
    Hughes, S. G.
    Kwoh, J.
    Jung, S. W.
    Guthrie, S.
    Pollock, M.
    Benson, M. D.
    Gertz, M.
    Coelho, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 92 - 92
  • [50] LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
    MacDiarmid, Scott
    Nicandro, J. P.
    Cheng, Maria
    Abrams, Steven
    Fein, Seymour
    Wein, Alan
    JOURNAL OF UROLOGY, 2017, 197 (04): : E398 - E398